Biomedical Engineering Reference
In-Depth Information
. 28.. Thurston,.G.,.McLean,.J..W.,.Rizen,.M.,.Baluk,.P.,.Haskell,.A.,.Murphy,.T..J.,.Hanahan,.D.,.and.
McDonald,.D..M.,.Cationic.liposomes.target.angiogenic.endothelial.cells.in.tumors.and.chronic.
inlammation.in.mice,.
Journal of Clinical Investigation
.101.(7),.1401-1413,.1998.
. 29.. Krasnici,.S.,.Werner,.A.,.Eichhorn,.M..E.,.Schmitt-Sody,.M.,.Pahernik,.S..A.,.Sauer,.B.,.Schulze,.B.,.
Teifel,.M.,.Michaelis,.U.,.Naujoks,.K.,.and.Dellian,.M.,.Effect.of.the.surface.charge.of.liposomes.
on. their. uptake. by. angiogenic. tumor. vessels,.
International Journal of Cancer
. 105. (4),. 561-567,.
2003.
. 30.. Maeda,. H.,. The. enhanced. permeability. and. retention. (EPR). effect. in. tumor. vasculature:. the.
key. role. of. tumor-selective. macromolecular. drug. targeting,. in.
41st International Symposium
on Regulation of Enzyme Activity and Synthesis in Normal and Neoplastic Tissues
,. G.. Weber,.
Indianapolis,.IN,.2000,.pp..189-207.
. 31.. Owens,.D..E.,.and.Peppas,.N..A.,.Opsonization,.biodistribution,.and.pharmacokinetics.of.poly-
meric.nanoparticles,.
International Journal of Pharmaceutics
.307.(1),.93-102,.2006.
. 32.. Allen,.T..M.,.and.Chonn,.A.,.Large.unilamellar.liposomes.with.low.uptake.into.the.reticuloen-
dothelial.system,.
FEBS Letters
.223.(1),.42-46,.1987.
. 33.. Lee,. V.. H.. L.,. Nanotechnology:. challenging. the. limit. of. creativity. in. targeted. drug. delivery,.
Advanced Drug Delivery Reviews
.56.(11),.1527-1528,.2004.
. 34.. Rossi,.J.,.Giasson,.S.,.Khalid,.M..N.,.Delmas,.P.,.Allen,.C.,.and.Leroux,.J..C.,.Long-circulating.
poly(ethylene.glycol)-coated.emulsions.to.target.solid.tumors,.
European Journal of Pharmaceutics
and Biopharmaceutics
67.(2),.329-338,.2007.
. 35.. Boghaert,.E..R.,.Khandke,.K.,.Sridharan,.L.,.Armellino,.D.,.Dougher,.M.,.DiJoseph,.J..F.,.Kunz,.
A.,.Hamann,.P..R.,.Sridharan,.A.,.Jones,.S.,.Discafani,.C.,.and.Damle,.N..K.,.Tumoricidal.effect.
of.calicheamicin.immuno-conjugates.using.a.passive.targeting.strategy,.
International Journal of
Oncology
.28.(3),.675-684,.2006.
. 36.. Peer,.D.,.Karp,.J..M.,.Hong,.S.,.FaroKhzad,.O..C.,.Margalit,.R.,.and.Langer,.R.,.Nanocarriers.as.
an.emerging.platform.for.cancer.therapy,.
Nature Nanotechnology
.2.(12),.751-760,.2007.
. 37.. Gottesman,.M..M.,.Mechanisms.of.cancer.drug.resistance,.
Annual Review of Medicine
.53,.615-
627,.2002.
. 38.. Ciardiello,.F.,.and.Tortora,.G.,.A.novel.approach.in.the.treatment.of.cancer:.targeting.the.epider-
mal.growth.factor.receptor,.
Clinical Cancer Research
.7.(10),.2958-2970,.2001.
. 39.. Blume-Jensen,. P.,. and. Hunter,. T.,. Oncogenic. kinase. signalling,.
Nature
. 411. (6835),. 355-365,.
2001.
. 40.. Longati,.P.,.Comoglio,.P..M.,.and.Bardelli,.A.,.Receptor.tyrosine.kinases.as.therapeutic.targets:.
the.model.of.the.MET.oncogene,.
Current Drug Targets
.2.(1),.41-55,.2001.
. 41.. Smith,.J..K.,.Mamoon,.N..M.,.and.Duhe,.R..J.,.Emerging.roles.of.targeted.small.molecule.pro-
tein-tyrosine.kinase.inhibitors.in.cancer.therapy,.
Oncology Research
.14.(4-5),.175-225,.2004.
. 42.. Mendelsohn,.J.,.and.Baselga,.J.,.The.EGF.receptor.family.as.targets.for.cancer.therapy,.
Oncogene
.
19.(56),.6550-6565,.2000.
. 43.. Mendelsohn,.J.,.Epidermal.growth.factor.receptor.inhibition.by.a.monoclonal.antibody.as.anti-
cancer.therapy,.in.
Symposium on Foundations of Clinical Cancer Research—Perspective for the 21st-
Century
,.Houston,.TX,.1997,.pp..2703-2707.
. 44.. Morrison,.S..L.,.Johnson,.M..J.,.Herzenberg,.L..A.,.and.Oi,.V..T.,.Chimeric.human-antibody.mol-
ecules—mouse.antigen-binding.domains.with.human.constant.region.domains,.
Proceedings of
the National Academy of Sciences of the United States of America—Biological Sciences
.81.(21),.6851-
6855,.1984.
. 45.. Lobuglio,.A..F.,.Wheeler,.R..H.,.Trang,.J.,.Haynes,.A.,.Rogers,.K.,.Harvey,.E..B.,.Sun,.L.,.Ghrayeb,.
J.,. and. Khazaeli,. M.. B.,. Mouse. human. chimeric. monoclonal-antibody. in. man—kinetics. and.
immune.response,.
Proceedings of the National Academy of Sciences of the United States of America
.
86.(11),.4220-4224,.1989.
. 46.. Hale,. G.,. Clark,. M.. R.,. Marcus,. R.,. Winter,. G.,. Dyer,. M.. J.. S.,. Phillips,. J.. M.,. Riechmann,. L.,.
and. Waldmann,. H.,. Remission. induction. in. non-Hodgkin. lymphoma. with. reshaped. human.
monoclonal-antibody.CAMPATH-1H,.
Lancet
.2.(8625),.1394-1399,.1988.
